메뉴 건너뛰기
Value in Health
Volumn 18, Issue 2, 2015, Pages 141-142
Clinical trials provide essential evidence, but rarely offer a vehicle for cost-effectiveness analysis
Author keywords

[No Author keywords available]
Indexed keywords

COST EFFECTIVENESS ANALYSIS; DECISION MAKING; EDITORIAL; EVIDENCE BASED MEDICINE; EVIDENCE BASED PRACTICE; FOLLOW UP; HEALTH CARE SYSTEM; HEALTH INSURANCE; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESOURCE ALLOCATION; CLINICAL TRIAL (TOPIC); COST BENEFIT ANALYSIS; ECONOMICS; PROCEDURES;
EID: 84924905779     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2015.02.005     Document Type: Editorial
Times cited : (13)
References (8)
  • 1
    • 33745964138 scopus 로고    scopus 로고
    • Whither trial-based economic evaluation for health care decision making?
    • M.J. Sculpher, K.P. Claxton, and M.F. Drummond Whither trial-based economic evaluation for health care decision making? Health Econ 15 2006 677 687
    • (2006) Health Econ , vol.15 , pp. 677-687
    • Sculpher, M.J.1    Claxton, K.P.2    Drummond, M.F.3
  • 2
    • 84924857556 scopus 로고    scopus 로고
    • Cost-effectiveness analysis alongside clinical trials II - An ISPOR Good Research Practices Task Force report
    • S.D. Ramsey, R.J. Willke, and F. Augustovski Cost-effectiveness analysis alongside clinical trials II - an ISPOR Good Research Practices Task Force report Value Health 18 2015 161 172
    • (2015) Value Health , vol.18 , pp. 161-172
    • Ramsey, S.D.1    Willke, R.J.2    Augustovski, F.3
  • 3
    • 29644441432 scopus 로고    scopus 로고
    • Cost-effectiveness of drug-eluting coronary artery stenting in a UK setting: Cost-utility study
    • A. Bagust, A. Grayson, and N. Palmer Cost-effectiveness of drug-eluting coronary artery stenting in a UK setting: cost-utility study Heart 92 2006 68 74
    • (2006) Heart , vol.92 , pp. 68-74
    • Bagust, A.1    Grayson, A.2    Palmer, N.3
  • 4
    • 20144389264 scopus 로고    scopus 로고
    • Management of non-ST-elevation acute coronary syndromes: How cost-effective are glycoprotein IIb/IIIa antagonists in the UK National Health Service?
    • S. Palmer, M. Sculpher, and Z. Philips Management of non-ST-elevation acute coronary syndromes: how cost-effective are glycoprotein IIb/IIIa antagonists in the UK National Health Service? Int J Cardiol 100 2005 229 240
    • (2005) Int J Cardiol , vol.100 , pp. 229-240
    • Palmer, S.1    Sculpher, M.2    Philips, Z.3
  • 6
    • 79959960493 scopus 로고    scopus 로고
    • Conducting indirect-treatment-comparison and network-meta-analysis studies: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 2
    • D.C. Hoaglin, N. Hawkins, and J.P. Jansen Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2 Value Health 14 2011 429 437
    • (2011) Value Health , vol.14 , pp. 429-437
    • Hoaglin, D.C.1    Hawkins, N.2    Jansen, J.P.3
  • 7
    • 35148878256 scopus 로고    scopus 로고
    • B streptococcal and other bacterial infections in early infancy: Cost effectiveness and value of information analyses
    • Preventive strategies for group
    • T. Colbourn, C. Asseburg, L. Bojke Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses BMJ 335 2007 655 662
    • (2007) BMJ , vol.335 , pp. 655-662
    • Colbourn, T.1    Asseburg, C.2    Bojke, L.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.